Massimo Federico, MD, University of Modena and Reggio Emilia, Modena, Italy, discusses response oriented maintenance therapy in advanced follicular lymphoma, explaining the results of the interim analysis of the FOLL12 trial (NCT02063685). This interview took place at the 15th International Conference on Malignant Lymphoma (ICML), in Lugano, Switzerland.
